摘要
目的:观察舒血宁注射液对急性脑梗死患者血浆C反应蛋白(CRP)和血栓素B2(TXB2)水平的影响,探讨舒血宁注射液治疗急性脑梗死的机制。方法将90例患者急性脑梗死患者随机分为舒血宁治疗组和丹参治疗组,在治疗前及治疗后第15天检测血浆CRP(免疫比浊法)和TXB2(双抗体夹心ELISA法)含量。结果急性脑梗死病人治疗前血浆CRP、TXB2的含量较健康对照组明显增加(P<0.05)。经舒血宁、复方丹参注射液治疗后血浆CRP、TXB2的含量明显下降(P<0.05),但仍然高于健康对照组(P<0.05)。与丹参治疗组相比,舒血宁治疗组CRP、TXB2的下降更为明显(P<0.05)。结论舒血宁注射液治疗急性脑梗死的疗效可能与使急性脑梗死患者血浆CRP和TXB2水平下降有关。
Objective To investigate the effect of Shuxuening injection on C-reactive protein(CRP)and thromboxane B2(TXB2)levels in plasma of acute cerebral infarction patients,and elucidate the possible mechanism of Shuxuening injection in treatment of acute cerebral infarction.Methods 100 acute cerebral infarction patients were randomly divided into Shuxuening and Danshen-treated group.Before and 15 days after treatment,CRP and TXB2 levels in plasma were detected.Results Before treatment,the CRP and VEGF levels of ac...
出处
《医药世界》
2007年第S1期68-70,共3页
Medicine World
关键词
舒血宁注射液
急性脑梗死
C反应蛋白
血栓素B2
Shuxuening Injection
acute cerebral infarction
C-reactive protein
Thromboxane B_2
